Streptococcus pyogenes (group A Streptococcus, or GAS) causes 23 600 million cases of pharyngitis each year. Despite this considerable disease 24 burden, the molecular mechanisms used by GAS to infect, cause clinical 25 pharyngitis, and persist in the human oropharynx are poorly understood. Saliva is 26 ubiquitous in the human oropharynx and is the first material GAS encounters in 27 the upper respiratory tract. Thus, a fuller understanding of how GAS survives and 28 proliferates in saliva may provide valuable insights into the molecular 29 mechanisms at work in the human oropharynx. We generated a highly saturated 30 transposon insertion mutant library in serotype M1 strain MGAS2221, a strain 31 genetically representative of a pandemic clone that arose in the 1980s and 32 spread globally. The transposon mutant library was exposed to human saliva to 33 screen for GAS genes required for wild-type fitness in this clinically relevant fluid. 34
responsible for an additional 100 million cases of other human infections each 81
year, many of which occur after initial colonization of the oropharynx (3). These 82 additional infections include acute rheumatic fever and subsequent rheumatic 83 heart disease, and as a consequence is the most common cause of preventable 84 pediatric heart disease globally (3, 6) . The majority of cases of rheumatic fever 85 occur following human upper respiratory tract infection. Despite the extensive toll 86 on human health, the molecular mechanisms used by GAS to successfully 87 colonize, cause acute pharyngitis and persist in the human oropharynx remain 88 largely unknown or poorly understood (7, 8) . This lack of knowledge constitutes a 89 critical knowledge gap in our understanding of GAS pathogenesis, and thus 90 represents an opportunity for enhanced understanding of the molecular 91 mechanisms at work during the critical initial pathogen interaction with the human 92 host. 93
The oropharynx is the primary site of entry for GAS into the body and the 94 major portal of person-to-person transmission (9) (10) (11) . Several observations have 95 stimulated our interest in studying the molecular genetic basis of interaction 96 between human saliva and GAS. Saliva is ubiquitous in the human oropharynx 97 and is the first host material contacted by GAS in its common transmission cycle. 98
Compared to individuals with clinical pharyngitis who lack GAS in their saliva, 99 patients with GAS present in their saliva are more likely to transmit the organism 100 to a new host by aerosolization (10-12). Thus, understanding how GAS survives 101 and proliferates in saliva and the oropharynx may provide valuable insights into 102 the molecular mechanisms underlying successful bacterial interaction in this 103
niche. 104
Previous studies addressing GAS-saliva interactions have identified 105 several factors that contribute to bacterial fitness (13-18), but knowledge is 106 limited. The studies conducted by Sitkiewicz et al. (13) and Virtaneva et al. (14, 107 15) investigated gene responses of a serotype M1 GAS strain grown in human 108 saliva ex vivo (16) . Subsequently, Shelburne et al (17) identified a key two-109 component transcriptional regulatory system (SptR/S) of previously unknown 110 function that plays central role in optimizing GAS persistence in saliva. The 111
SptR/S two-component system influences multiple GAS metabolic pathways and 112 production of many virulence factors (17). For example, the secreted virulence 113 factors streptococcal inhibitor of complement (Sic) and a potent extracellular 114 cysteine protease (SpeB) made by GAS during growth ex vivo in saliva 115 contribute significantly to GAS persistence in this fluid (16) . Additional 116 information about GAS interaction in the oropharynx was provided by a 20-117 monkey study that investigated global transcriptome changes occurring over 86 118 days of the infection cycle, including initial colonization, acute clinical pharyngitis, 119 and ultimately asymptomatic colonization (15, 18) . Taken together, these studies 120 have provided a broad overview of some of the GAS processes at work in the 121 oropharynx; however, much remains to be learned. 122
Especially lacking is a detailed understanding of the genes required for 123 successful growth and persistence in saliva. To address this important 124 knowledge gap, we conducted a genome-wide screen to identify GAS genes 125 contributing to fitness in human saliva ex vivo. Using transposon-directed 126 insertion site sequencing (TraDIS) (19-28), we generated a highly saturated 127 transposon insertion library (140,249 unique transposon insertions) in serotype 128 M1 reference strain MGAS2221 (29-31). This serotype was used because it is 129 usually the most common cause of pharyngitis and other human infections in 130 western countries (3). Strain MGAS2221 is genetically representative of the 131 pandemic clone that arose in the 1980s and rapidly spread globally (29) (30) (31) (32) . The 132 transposon mutant library was exposed to human saliva ex vivo for 48 hrs to 133 identify GAS genes contributing to fitness over time in this clinically relevant fluid. 134
Saliva studies conducted with six isogenic mutant strains validated the findings. 135
The new information we obtained substantially increases our overall 136 understanding of the molecular genetic basis of pathogen-saliva interactions and 137 is valuable for future translational research designed to treat or prevent human 138 GAS infections. 139 140 141
RESULTS

143
Construction of a highly saturated transposon insertion library in 144 serotype M1 GAS strain MGAS2221. A transposon insertion mutant library was 145 generated using serotype M1 strain MGAS2221 as the parental organism. Strain 146 MGAS2221 was chosen for transposon mutagenesis because (i) it is genetically 147
representative of a pandemic clone that arose in the 1980s and disseminated 148 worldwide (30-32), (ii) MGAS2221 has wild-type alleles of major transcriptional 149 regulators that affect virulence, such as covR/covS, ropB, mga, and rocA, and 150 (iii) it has been used in many mouse and primate infection studies (31). Using 151 plasmid pGh9:ISS1 (26), we successfully generated a dense transposon mutant 152 library in strain MGAS2221 containing 140,249 unique transposon insertions. On 153 average, the library contains one transposon insertion every 13 nucleotides. 154 93.4% of the genes in the MGAS2221 genome (1720 out of 1841) have at least 155 one transposon insertion. The nearly random distribution of transposon insertion 156 and high density of transposon insertions in the S. pyogenes genome is 157 illustrated in Fig. 1 . By analyzing the mutant library using the tradis_essentiality 158
TraDIS toolkit script (25), we identified 432 genes (~23.5% of the genes in the 159 genome) that are essential for the serotype M1 GAS strain MGAS2221 in our experimental conditions (40°C, in THY broth supplemented with 0.5 µg/ml 161 erythromycin, see Materials and Methods). The list of identified essential genes 162 is presented in Table S1 . 163
Genes contributing to fitness of GAS over time in human saliva. We 164 exposed the transposon mutant library to pooled human saliva ex vivo to screen 165 for genes contributing to fitness in this fluid. TraDIS was used to identify genes 166 with significantly altered mutant frequency in the output mutant pools compared 167 to the input pool at 12, 24, and 48 hrs after saliva inoculation. Genes with 168 significantly decreased mutant frequency (fold-change >1.5, and q value < 0.1) in 169 the output mutant pools were regarded as important for saliva growth and 170 persistence, which can be referred to as fitness. To ensure that the statistical 171 power was adequate, genes with fewer than 10 transposon insertions in any of 172 the four input mutant pools were excluded from the analysis, as recommended 173 by van Opijnen et al (33) . 174
We identified 30 (12 hrs), 42 (24 hrs) and 83 (48 hrs) genes with 175 significantly decreased mutant frequencies, providing evidence that these genes 176 contribute to GAS fitness in human saliva ( Fig. 2 and Fig. 3 , Table S2 ). In total, 177 92 genes were identified at the three time points (Fig. 3A , Table S2 ). Clusters of 178 orthologous groups (COG) classification of the 92 genes showed that 179 numerically, the three more prevalent categories include genes involved in 180 carbohydrate transport and metabolism (n = 10 genes), amino acid transport and 181 metabolism (n = 8 genes), and inorganic ion transport and metabolism (n = 7 182 genes) ( Fig. 3B ). Our previously published data from an experimental pharyngitis infection study, involving 20 cynomolgus macaques (15), identified genes 184 expressed during GAS oropharyngeal infection. Of the 92 saliva-fitness genes 185 identified by TraDIS, ~74% were also expressed during GAS oropharyngeal 186 infection (Table S2 ). Moreover, many of these 92 genes (e.g., nagA, pstS, oppA, 187 and malX) are upregulated during GAS oropharyngeal infection in cynomolgus 188 macaques (15). Together, our results suggest that many of the GAS genes 189 contributing to fitness in saliva ex vivo may also contribute to pathogen fitness in 190 the oropharynx of non-human primates (NHPs). However, experiments will be 191 required to directly test this hypothesis. 192
Additionally, we determined that some genes at 12 hr (n = 8 genes), 24 hr 193 (n = 21 genes) and 48 hr (n = 41 genes) were significantly associated with 194 potentially increased GAS fitness in saliva. The magnitude of the fold-change in 195 these genes was relatively modest compared to the genes that were decreased 196 in fitness ( Fig. 2A -C, Table S3 ). 197
The fitness score of all genes in the M1 GAS genome (including the genes 198 with less than 10 insertions) with significant change in sequence read counts at 199 the three time points (12 hr, 24 hr and 48 hr) are listed in Table S4 , Table S5 , 200
and Table S6 , respectively. 201
Validation of six genes required for wild-type GAS fitness in human 202
saliva ex vivo. To validate the TraDIS screen findings, we analyzed the saliva 203 fitness phenotype of each isogenic mutant strain generated from six genes 204 (spy0644, spy0646, lacR.1, carB, nifS1, and pstS) identified in the screen. 205
These six genes were chosen for analysis because (i) they have not been 206 previously shown to participate in GAS fitness in human saliva, (ii) transposon 207 insertions into these genes represented a range of altered fitness fold-change 208 values, (iii) the genes are present in the core genome of all sequenced GAS 209 genomes, (iv) the genes are known to be expressed in the oropharynx of NHPs 210 during experimental infection (15), and (v) these genes participate in a variety of 211 biological pathways: spy0644 and spy0646 (putative ABC transporter), lacR.1 212 (carbohydrate metabolism), carB (pyrimidine and arginine synthesis), nifS1 213 (amino acid metabolism) and pstS (phosphate transport). To test the hypothesis 214 that inactivating each of these six genes impaired GAS fitness in human saliva ex 215 vivo, we used targeted insertional mutagenesis (31, 34, 35) to create isogenic 216 mutant strains from wild-type parental strain MGAS2221. The genome of each 217 isogenic strain was sequenced before use to ensure that no spurious mutations 218 had been introduced during mutant construction. Consistent with our hypothesis, 219 the results (Fig. 4 ) confirmed that these six isogenic mutant strains had 220 significantly decreased fitness in human saliva compared to parental strain 221 MGAS2221 ( Fig. 4) . Importantly, we discovered that mutant strains Δspy0644 222
and Δspy0646 had severely impaired fitness in saliva ( Fig. 4A ). Greater than 223 99% of the Δspy0644 and Δspy0646 inocula were not present as viable cells at 224 the 24 hr time point post-saliva inoculation (Fig. 4A ). Genes spy0644, spy0645, 225 and spy0646 likely constitute an operon that encodes an ABC transporter system 226 ( Fig. 4A and Table S2 ). On the basis of genome sequencing of thousands of 227 strains of 20 evolutionarily diverse M protein serotypes commonly causing 228 human infections, these three genes are part of the core genome of GAS (32, 229 36). That is, these genes are present in all GAS genomes sequenced and 230 moreover, they are highly conserved in genome location and context, and 231 primary amino acid sequence. In addition, homologs of this three-gene region 232 are present in related species of pathogenic streptococci, including 233
Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus equi, 234
Streptococcus gallolyticus, Streptococcus mutans and others, and are conserved 235 in location downstream of carB (Fig. 5 ). This suggests a functional relationship 236 exists between this ABC transporter and the metabolic activities of CarB. In this 237 regard, we also identified carB to be important for wild-type GAS fitness in saliva 238 (Table S2) , and confirmed that the ΔcarB isogenic mutant strain is significantly 239 impaired in persistence in saliva ( Fig. 4B) . carB encodes the large subunit of 240 carbamoylphosphate synthetase (37, 38) . Carbamoylphosphate is a precursor for 241 both pyrimidine and arginine synthesis (38). Interestingly, carB also was reported 242 to be required for GAS fitness in human blood, a body fluid with a very different 243 chemical composition to saliva (39). These results indicate that pyrimidine and 244 arginine synthesis mediated in part by carB contributes to GAS fitness in multiple 245 host niches. The ΔpstS mutant strain is also significantly attenuated for growth in 246 human saliva (Fig. 4E) . pstS encodes a putative phosphate binding protein and is 247 part of a six-gene operon encoding a phosphate uptake system (Fig. 4E) . A 248 genome-wide transposon mutagenesis screen found that pstS is required for the 249 fitness of Streptococcus pneumoniae in human saliva ex vivo (40). We also note 250 that pst operon genes have been reported to contribute to the virulence of 251 multiple gram-negative pathogens, including Proteus mirabilis and Escherichia coli (41-45). These results suggest efficient phosphate uptake is important for 253 fitness of multiple human and animal pathogens that must successfully interact 254 with their specific host niches, including saliva in the oropharynx. Growth of the 255 six mutants in rich medium in vitro (THY) showed that none of the mutants has 256 severe growth defects (Fig. 4F) . To summarize, the saliva growth phenotype of 257 these six isogenic mutant strains strongly reflected the fitness data obtained from 258 the high-throughput TraDIS screen. Our results present for the first time a genome-wide view of the GAS genes 264 contributing to pathogen fitness in human saliva, only the second pathogen (40) 265 for which such a screen has been performed. The work also represents the first 266 application of TraDIS to GAS, a human-specific pathogen responsible for greater 267 than 700 million infections each year, including 600 million pharyngitis cases (3). 268
Some years ago we initiated study of GAS-human saliva molecular 269 interactions (16) with the goal of obtaining new insight into GAS gene activity 270 during the earliest stage of oropharyngeal infection. A common theme that has 271 emerged from many studies (16, 17, 46, 47) is that genes involved in complex 272 carbohydrate catabolism play important roles in growth and persistence in human 273 saliva. Saliva in the human oropharynx contains many nutrients and diverse 274 molecules critical to innate and acquired immunity (48) (49) (50) . Knowledge gained 275 about how GAS responds to saliva contributes to a broader understanding of 276 host-pathogen interaction and microbial persistence on mucosal surfaces. 277
Expression microarray analysis, immunologic methods, and in vivo gene 278 quantification identified a genetic program used by GAS to survive in human 279 saliva ex vivo (14, 16, 17) . A key discovery was that a two-component regulatory 280 system (TCS) of previously unknown function played a central role in pathogen 281 survival in saliva (17), and revealed an intimate link between metabolism, 282 virulence factor production, and GAS persistence in saliva. However, the 283 strategy used was unable to directly identify the specific genes contributing to 284 GAS persistence in saliva. Our TraDIS analysis discovered that 25 of 92 (27%) 285 genes contributing to fitness in human saliva ex vivo are involved in 286 carbohydrate, amino acid and inorganic ion transport and/or metabolism. 287
Inactivation of genes in these categories is likely to significantly impair core 288 metabolic processes such as nutrient acquisition and use. Our results add to the 289 important theme of an intimate linkage between metabolism and GAS 290 persistence in human saliva. We note that a similar spectrum of genes was 291 abundantly represented in an ex vivo human saliva transposon mutagenesis 292 screen conducted for S. pneumoniae (40). For example, the opp operon (oligo 293 peptide transport) and pst operon (phosphate uptake) are required for fitness in 294 both GAS and S. pneumoniae (40) ( Table S2 ), suggesting certain mechanisms 295 contributing to bacterial fitness in saliva are shared by multiple pathogens in the 296 oropharyngeal niche. 297
By mining data available from our previously conducted NHP pharyngitis 298 study, we found that a large majority (74%, see Table S2 ) of the 92 genes 299 discovered herein to contribute to fitness in human saliva also were expressed in 300 vivo in the monkey oropharynx (15). Several explanations may account for the 301 lack of evidence for expression of 24% of the genes. First, the NHP study was 302 conducted relatively early in our understanding of the annotation of the genome 303 of the input serotype M1 strain MGAS5005. It is possible that not all of the 304 genome of MGAS5005 was represented on the Affymetrix gene chip used in that 305 study. Second, it is possible that some of the genes were expressed, but at 306 levels too low to detect with the techniques available at that time. Third, it may be 307 that some of the genes in MGAS2221 are expressed at different time points than 308 we used in the two studies, for example farther into the asymptomatic carriage 309 phase (that is, later than day 7), the end point used in our current study. Finally, 310 human saliva ex vivo is a different environment than the primate oropharynx, a 311 niche that also contains, for example, host innate and acquired immune cells and 312 epithelial cells. Therefore, it was not unexpected to find potential differences in 313 evidence of gene expression between the two data sets. Despite this, the 314 remarkable 74% gene overlap unambiguously shows that many similar 315 mechanisms are at work on GAS regardless of whether it is exposed to human 316 saliva ex vivo or inoculated into the primate oropharynx. 317
For decades, the analysis of GAS-mediated processes contributing to 318 pharyngitis was restricted predominantly to inferences obtained by evaluating 319 serologic responses to relatively few extracellular molecules that participate in 320 pathogen-host molecular interactions, such as M protein, DNase B, and 321 streptolysin O (51-53). Although important information has been obtained from 322 these descriptive studies, the inability to directly identify large numbers of GAS 323 genes contributing to pharyngitis means that we have a very imprecise 324 understanding of molecular processes contributing to this important human 325 infection. Given the 74% overlap in genes between our TraDIS screen and NHP 326 pharyngitis expression data, it is reasonable to conclude that our study advances 327 understanding of molecular events occurring in the oropharynx, and thereby 328 provides a critical foundation for subsequent molecular pathogenesis studies. 329
Growth and persistence in human saliva contributes to the ability of GAS 330 to be successfully transmitted by respiratory droplets. The work of Hamburger 331
(9-11) demonstrated that individuals with higher CFUs of GAS in saliva were 332 more likely to transmit the organism to others. This observation implies that any 333 process detrimentally affecting fitness in saliva (such as gene inactivation as 334 done herein) is likely to decrease the probability of successful transmission. It 335 also suggests that mutants with substantial fitness defects are more highly likely 336 to have decreased ability to disseminate and/or cause clinical pharyngitis. The 337 isogenic mutants constructed by inactivation of spy0644 (herein denoted sptA, 338 for streptococcal persistence) and spy0646 (sptC) had the most pronounced 339 growth phenotype of the six isogenic mutant strains during saliva growth ex vivo. 340
Of note, the transposon mutants of these two genes had the lowest fitness 341 scores at the early time point (12 hr) of any of the six mutants we tested ( Table  342 S2). In contrast, according to the screen, carB and lacR.1 transposon mutants have significantly decreased fitness only at the latest time point (48 hr) ( Table  344 S2). Isogenic mutants ΔcarB and ΔlacR.1 had a moderate saliva growth 345 phenotype compared to the ΔsptA and ΔsptC strains ( Fig. 4B and C) . These 346 findings suggest that a relationship exists between magnitude of the fold-change 347 at an early time point and growth of the resulting isogenic mutant strain in saliva 348 ex vivo. However, more data generated with additional isogenic mutant strains is 349 required to rigorously test this idea. If true, use of these data could be an 350 important characteristic used to help triage GAS genes for more in depth 351
analysis, including translation research activities. 352
Our results show that mutants with insertions in pst operon genes are 353 significantly attenuated for growth in human saliva (Fig. 4E , Table S2 ). The pst 354 operon encodes a high-affinity phosphate transporter and has been reported to 355 contribute to bacterial virulence and fitness in a wide variety of pathogens (41, 356 43-45, 54-56) . For example, genome-wide transposon mutagenesis screens 357 found that pst operon is required for the fitness of S. pneumoniae in human 358 saliva ex vivo (40) and mouse lung infections (57). In the oral pathogen S. 359 mutans, deleting pstS results in decreased production of extracellular 360 polysaccharide, and reduced ability to adhere to saliva-coated surfaces (56). 361
The pst operon genes in gram-negative pathogens, have been reported to 362 contribute to the virulence of Proteus mirabilis and Escherichia coli (41) (42) (43) (44) (45) 54) . 363
Together, these results suggest efficient phosphate uptake is important for the 364 ability of multiple human and animal pathogens to survive and thrive in their 365 specific host niches, including S. pyogenes in human saliva. 366
The transposon mutagenesis screen study we performed has several 367 limitations. In the human oropharynx, saliva is constantly replenished, whereas 368 in our experimental system a single aliquot of pooled saliva was used for the 369 entire incubation period. A second important limitation is the lack of intact 370 immune cells contributing to innate and acquired immunity in the saliva 371 preparation used. These and other cells (e.g., epithelial) are lacking because the 372 saliva is filter-sterilized prior to use. It is also possible that very small genes were 373 missed in the screen because we excluded genes with fewer than 10 inserts from 374 the analysis, a common practice in transposon mutagenesis studies (33, 58) . 375
Overcoming some of these limitations will require experimental infection of an 376 intact animal that faithfully recapitulates all phases of human pharyngitis, such as 377 NHPs. A third limitation is the six isogenic mutants we used to validate the 378 TraDIS results were generated by insertional inactivation. Although the isogenic 379 mutants have no spurious mutations, and their phenotype recapitulated the 380 TraDIS findings, this does not rule out potential polar effects on neighboring 381 genes, especially genes located in the same operon. To overcome this limitation 382 in future follow-up in-depth functional studies on key genes and operons 383
identified in this initial screen, non-polar deletion mutants and complemented 384 mutant strains can be used. 385
To summarize, by identifying genes contributing to fitness in human saliva 386 ex vivo, our work complements important information obtained in other 387 transposon mutant screens that identified GAS genes contributing to fitness in 388 human blood ex vivo and mouse soft tissue disease after subcutaneous infection, 389 and for growth in vitro (39, 59, 60) . It is reasonable to suggest that the 390 information we obtained from this genome-wide screen for genes contributing to 391 fitness in human saliva can be successfully exploited for future pathogenesis 392 investigations. 393 394 395
MATERIALS AND METHODS 396
Bacterial strains and growth conditions. Strain MGAS2221 is 397 genetically representative of a pandemic clone of serotype M1 that arose in the 398 1980s and has spread worldwide (30-32). Isogenic mutant strains ΔcarB, 399
ΔlacR.1, ΔsptA, ΔsptC, ΔnifS1, ΔpstS were derived from parental strain 400 MGAS2221, the organism used for construction of the transposon mutant library. 401
All GAS strains were grown in Todd-Hewitt broth supplemented with 0.2% yeast 402 extract (THY broth) at 37°C with 5% CO 2 . 403
Generation of GAS transposon mutant library. A transposon mutant 404
library was generated in strain MGAS2221 using transposon plasmid pGh9:ISS1 405 based on a recently described protocol (26). Briefly, pGh9:ISS1 was transformed 406 into strain MGAS2221 by electroporation (26). A single colony of the 407 transformants was picked and grown overnight at 28°C (permissive temperature) 408 in THY broth supplemented with 0.5 µg/ml erythromycin. The resulting overnight 409 culture was heat shocked at 40°C (nonpermissive temperature) for 3 hrs to 410 permit random transposition and integration of pGh9:ISS1 into the GAS genome. 411
The GAS cells in the culture were harvested by centrifugation, plated on THY 412 agar supplemented with 0.5 µg/ml erythromycin, and grown overnight at 37°C. 413
The transposon mutant library (i.e., pooled transposon mutants) was collected by 414 washing the colonies off the agar plates with THY broth containing 25% glycerol. 415
The bacterial cell suspension (transposon mutant library) was stored at -80°C. 416
This process was repeated on three separate occasions and the three libraries 417 were pooled. 418
Human saliva collection and processing. Human saliva was collected 419 and processed as described previously (16, 17) . Briefly, saliva was collected 420 from five healthy donors, pooled, clarified by centrifugation at 45,000 x g for 15 421 min and sterilized with a 0.20 µm filter (Corning Inc.). The resulting sterile saliva 422 was used for subsequent transposon mutant library screening and individual 423 strain growth. 424
Exposure of the transposon mutant library to human saliva ex vivo. 425
The transposon mutant library was inoculated into 20 ml of THY and grown at 426 37°C to mid-exponential phase (OD = 0.5). The bacteria were harvested by 427 centrifugation and washed three times with an equal volume of PBS to remove 428 trace THY broth. 50 µl of the cell suspension in PBS was inoculated into four 429 tubes, each containing 40 ml of filtered saliva (Fig. S1 ). The four inoculated tubes 430 constitute four biological replicates of the saliva persistence assay (Fig. S1) . 431
Immediately after inoculation, 200 µl of the inoculated saliva from each of the four 432 replicate cultures was plated onto four THY plates, and incubated at 37°C for 12 433 hrs. GAS cells growing on the plates were harvested and represent the 434 composition of the input mutant pools (0 hr mutant pools, n = 4). Mutant pools 435 present at 12 hrs, 24 hrs and 48 hrs post-inoculation were recovered by plating 436 200 µl of the inoculated saliva onto THY agar plates at the aforementioned time 437 points and incubated for 12 hrs at 37°C. The collected mutant pools (4 replicates, 438 4 time points, n = 16) were stored at -80°C for the subsequent TraDIS analysis. 439 DNA preparation and massive parallel sequencing. Genomic DNA 440 preparation and DNA sequencing was performed according to procedures 441 described previously for TraDIS analysis, with minor modifications (26). Briefly, 442 genomic DNA of mutant pools collected at the various time points was isolated 443
using DNeasy blood & tissue kit (Qiagen). 2 µg purified genomic DNA was 444 fragmented by incubating with NEBNext dsDNA Fragmentase (New England 445 Biolabs) for 25 min at 37 °C to obtain DNA fragments in the range of 200-1,000 446 bp. A Y-adaptor (26) ( Table S7 ) was ligated to 1 µg of fragmented DNA using the 447
NEBNext Ultra II DNA library prep kit for Illumina (New England Biolabs). The 448 adaptor-ligated DNA fragments were then purified using AMPure XP beads 449 (Agencourt, Beckman Coulter) and digested with restriction enzyme BamHI for 3 450 hrs at 37 °C to minimize the mapping of TraDIS reads to the transposon plasmid 451 backbone (26). The resulting DNA was purified, and 100 ng of the purified library 452 DNA was subjected to PCR using the specific ISS1 primer and one of the 8 453 indexing PCR primers per DNA library (Table S7 ), to amplify regions that span 454 the 5' end of ISS1 and the GAS genomic regions adjacent to the chromosomal 455 location of the transposon. The PCR amplified libraries were sequenced using a 456 single end 76-cycle protocol on a NextSeq550 instrument (Illumina) using a 457 custom Read 1 primer (Table S7 ) and a custom Index Read sequencing primer 458 (Table S7) . 
